Back to Bridgewater Associates, LP Bridgewater Associates, LP

MRNA

Showing 7 of 17 quarters

Position history for Bridgewater Associates, LPBridgewater Associates, LP's holdings in Moderna, Inc.

Yes. Bridgewater Associates holds 11,527 shares of MRNA (Moderna), worth $807,236, as of its Q2 2026 13F filing. It reduced the position by 63,295 shares (-84.6%) from Q1 2026. Bridgewater Associates has held MRNA since Q3 2025, across 4 quarterly 13F filings.

Current Value

$807,236

Current Shares

11,527

Total Value Change

+$807,236

Total Shares Change

+11,527

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11,527
-84.6%
$807,2360.0%$70.03
0
2026-Q1
Increased
74,822
+392.9%
$3.8M0.0%$50.80
43
2025-Q4
Decreased
15,181
-93.2%
$447,6880.0%$29.49
0
2025-Q3
New
222,210
-
$5.7M0.0%$25.83
37
2025-Q1
Exited
0
-100.0%
$00.0%$28.35
0
2024-Q4
New
605,782
-
$25.2M0.1%$41.58
47
2024-Q3
Exited
0
-100.0%
$00.0%$65.75
0

Other major holders of MRNA: Baillie Gifford & Co.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used